首页> 美国卫生研究院文献>European Journal of Human Genetics >Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations
【2h】

Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations

机译:先天性蛋白丢失性肠病:由于DGAT1突变导致脂质代谢的先天性错误

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein-losing enteropathy (PLE) is a clinical disorder of protein loss from the gastrointestinal system that results in hypoproteinemia and malnutrition. This condition is associated with a wide range of gastrointestinal disorders. Recently, a unique syndrome of congenital PLE associated with biallelic mutations in the DGAT1 gene has been reported in a single family. We hypothesize that mutations in this gene are responsible for undiagnosed cases of PLE in infancy. Here we investigated three children in two families presenting with severe diarrhea, hypoalbuminemia and PLE, using clinical studies, homozygosity mapping, and exome sequencing. In one family, homozygosity mapping using SNP arrays revealed the DGAT1 gene as the best candidate gene for the proband. Sequencing of all the exons including flanking regions and promoter regions of the gene identified a novel homozygous missense variant, p.(Leu295Pro), in the highly conserved membrane-bound O-acyl transferase (MBOAT) domain of the DGAT1 protein. Expression studies verified reduced amounts of DGAT1 in patient fibroblasts. In a second family, exome sequencing identified a previously reported splice site mutation in intron 8. These cases of DGAT1 deficiency extend the molecular and phenotypic spectrum of PLE, suggesting a re-evaluation of the use of DGAT1 inhibitors for metabolic disorders including obesity and diabetes.
机译:蛋白质丢失性肠病(PLE)是一种胃肠道蛋白质丢失的临床疾病,可导致低蛋白血症和营养不良。这种情况与广泛的胃肠道疾病有关。最近,在一个家庭中已经报道了与DGAT1基因中的双等位基因突变相关的先天性PLE的独特综合征。我们假设该基因的突变与婴儿期PLE的未诊断病例有关。在这里,我们使用临床研究,纯合性作图和外显子组测序研究了两个家庭中严重腹泻,低白蛋白血症和PLE的三个孩子。在一个家族中,使用SNP阵列进行纯合性作图揭示了DGAT1基因是先证者的最佳候选基因。该基因的所有外显子(包括侧翼区域和启动子区域)的测序都在DGAT1蛋白的高度保守的膜结合O-酰基转移酶(MBOAT)域中确定了一个新的纯合错义变体p。(Leu295Pro)。表达研究证实患者成纤维细胞中DGAT1的含量降低。在第二个家族中,外显子组测序鉴定了先前报道的内含子8中的剪接位点突变。这些DGAT1缺乏症的病例扩展了PLE的分子和表型谱,表明对肥胖和糖尿病等代谢性疾病使用DGAT1抑制剂的重新评估。 。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号